| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.812 | 0.001 | 0.812 | 5 Hydroxytryptamine 1D agonist | 0.461 0.001 DBMET00948 0.222 0.002 DBMET03667 0.364 0.002 DBMET03668 0.461 0.001 DBMET03669 0.181 0.003 DBMET03670 | ||
| 0.743 | 0.003 | 0.743 | 5 Hydroxytryptamine 1 agonist | 0.573 0.004 DBMET00948 0.412 0.005 DBMET03667 0.487 0.004 DBMET03668 0.573 0.004 DBMET03669 0.376 0.005 DBMET03670 | ||
| 0.725 | 0.002 | 0.725 | 5 Hydroxytryptamine 1D antagonist | 0.471 0.003 DBMET00948 0.113 0.019 DBMET03667 0.229 0.005 DBMET03668 0.471 0.003 DBMET03669 0.155 0.011 DBMET03670 | ||
| 0.651 | 0.003 | 0.651 | 5 Hydroxytryptamine 1B antagonist | 0.369 0.004 DBMET00948 0.089 0.029 DBMET03667 0.161 0.011 DBMET03668 0.369 0.004 DBMET03669 0.101 0.023 DBMET03670 | ||
| 0.587 | 0.004 | 0.587 | 5 Hydroxytryptamine agonist | 0.425 0.005 DBMET00948 0.185 0.016 DBMET03667 0.261 0.01 DBMET03668 0.425 0.005 DBMET03669 0.189 0.015 DBMET03670 | ||
| 0.493 | 0.003 | 0.493 | 5 Hydroxytryptamine 1B agonist | 0.348 0.004 DBMET00948 0.16 0.004 DBMET03667 0.25 0.004 DBMET03668 0.348 0.004 DBMET03669 0.165 0.004 DBMET03670 | ||
| 0.367 | 0.003 | 0.367 | 5 Hydroxytryptamine 3E antagonist | 0.263 0.011 DBMET00948 0.19 0.082 DBMET03667 0.242 0.02 DBMET03668 0.263 0.011 DBMET03669 0.212 0.045 DBMET03670 | ||
| 0.372 | 0.026 | 0.395 | Anticonvulsant | 0.146 0.134 DBMET00948 0.395 0.022 DBMET03667 0.146 0.134 DBMET03669 | DBMET03667 | |
| 0.354 | 0.009 | 0.354 | 5 Hydroxytryptamine 1E antagonist | 0.292 0.035 DBMET00948 0.224 0.104 DBMET03668 0.292 0.035 DBMET03669 | ||
| 0.408 | 0.093 | 0.408 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.372 0.127 DBMET03667 0.322 0.184 DBMET03668 | ||
| 0.284 | 0.011 | 0.284 | 5 Hydroxytryptamine 1 antagonist | 0.131 0.027 DBMET00948 0.131 0.027 DBMET03669 | ||
| 0.255 | 0.014 | 0.255 | Alpha 2b adrenoreceptor antagonist | 0.171 0.031 DBMET00948 0.095 0.079 DBMET03668 0.171 0.031 DBMET03669 | ||
| 0.213 | 0.005 | 0.28 | Myeloperoxidase inhibitor | 0.28 0.004 DBMET00948 0.102 0.032 DBMET03667 0.086 0.055 DBMET03668 0.28 0.004 DBMET03669 | DBMET03669 | |
| 0.211 | 0.003 | 0.211 | 5 Hydroxytryptamine 3B antagonist | 0.062 0.01 DBMET00948 0.037 0.024 DBMET03668 0.062 0.01 DBMET03669 | ||
| 0.264 | 0.057 | 0.399 | Interleukin antagonist | 0.276 0.053 DBMET00948 0.399 0.031 DBMET03667 0.276 0.053 DBMET03669 | DBMET03667 | |
| 0.275 | 0.075 | 0.302 | Insulysin inhibitor | 0.255 0.092 DBMET00948 0.302 0.057 DBMET03667 0.255 0.092 DBMET03669 | DBMET03667 | |
| 0.204 | 0.005 | 0.204 | Histamine N-methyltransferase inhibitor | 0.162 0.011 DBMET00948 0.075 0.073 DBMET03667 0.095 0.05 DBMET03668 0.162 0.011 DBMET03669 | ||
| 0.196 | 0.005 | 0.196 | Lanosterol 14 alpha demethylase inhibitor | 0.147 0.012 DBMET00948 0.193 0.005 DBMET03667 0.128 0.024 DBMET03668 0.147 0.012 DBMET03669 | ||
| 0.208 | 0.027 | 0.326 | Cell wall synthesis inhibitor | 0.192 0.033 DBMET00948 0.275 0.012 DBMET03667 0.164 0.052 DBMET03668 0.192 0.033 DBMET03669 0.326 0.009 DBMET03670 | DBMET03670 | |
| 0.196 | 0.018 | 0.247 | GABA receptor agonist | 0.147 0.037 DBMET00948 0.247 0.01 DBMET03667 0.094 0.084 DBMET03668 0.147 0.037 DBMET03669 | DBMET03667 | |
| 0.206 | 0.032 | 0.206 | 5 Hydroxytryptamine antagonist | |||
| 0.19 | 0.029 | 0.491 | DNA intercalator | 0.186 0.03 DBMET00948 0.491 0.005 DBMET03668 0.186 0.03 DBMET03669 0.158 0.039 DBMET03670 | DBMET03668 | |
| 0.248 | 0.09 | 0.248 | 5 Hydroxytryptamine release stimulant | 0.175 0.147 DBMET00948 0.18 0.14 DBMET03667 0.175 0.147 DBMET03669 | ||
| 0.164 | 0.014 | 0.164 | 5 Hydroxytryptamine 1F antagonist | 0.098 0.033 DBMET00948 0.098 0.033 DBMET03669 | ||
| 0.172 | 0.024 | 0.172 | Alpha 2c adrenoreceptor antagonist | 0.129 0.043 DBMET00948 0.129 0.043 DBMET03669 | ||
| 0.168 | 0.023 | 0.168 | 5 Hydroxytryptamine 2C antagonist | 0.079 0.062 DBMET00948 0.079 0.062 DBMET03669 | ||
| 0.214 | 0.088 | 0.214 | MAP-kinase-activated kinase 5 inhibitor | 0.193 0.112 DBMET00948 0.193 0.112 DBMET03669 | ||
| 0.267 | 0.14 | 0.297 | GABA C receptor rho-3 antagonist | 0.28 0.13 DBMET00948 0.297 0.118 DBMET03667 0.28 0.13 DBMET03669 | DBMET03667 | |
| 0.2 | 0.075 | 0.2 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.142 0.12 DBMET00948 0.142 0.12 DBMET03669 | ||
| 0.14 | 0.018 | 0.14 | GABA A receptor agonist | 0.097 0.04 DBMET00948 0.127 0.021 DBMET03667 0.097 0.04 DBMET03669 | ||
| 0.149 | 0.032 | 0.149 | Protein kinase C gamma inhibitor | 0.139 0.038 DBMET00948 0.093 0.091 DBMET03667 0.139 0.038 DBMET03669 | ||
| 0.137 | 0.02 | 0.137 | CYP2A6 inhibitor | |||
| 0.129 | 0.015 | 0.129 | Acetylcholine M4 receptor antagonist | 0.093 0.035 DBMET00948 0.093 0.035 DBMET03669 | ||
| 0.148 | 0.038 | 0.148 | Falcipain 3 inhibitor | 0.098 0.072 DBMET00948 0.098 0.072 DBMET03669 | ||
| 0.233 | 0.123 | 0.233 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.222 0.134 DBMET00948 0.222 0.134 DBMET03669 | ||
| 0.126 | 0.017 | 0.192 | Aromatase inhibitor | 0.149 0.013 DBMET00948 0.192 0.009 DBMET03667 0.079 0.028 DBMET03668 0.149 0.013 DBMET03669 0.081 0.027 DBMET03670 | DBMET03667 | |
| 0.122 | 0.015 | 0.122 | Benzodiazepine agonist | |||
| 0.113 | 0.013 | 0.113 | 5 Hydroxytryptamine 5A antagonist | 0.056 0.054 DBMET00948 0.056 0.054 DBMET03669 | ||
| 0.115 | 0.014 | 0.115 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.151 | 0.051 | 0.191 | M18 aspartyl aminopeptidase inhibitor | 0.191 0.036 DBMET00948 0.174 0.042 DBMET03667 0.14 0.057 DBMET03668 0.191 0.036 DBMET03669 | DBMET03669 | |
| 0.194 | 0.095 | 0.194 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.124 | 0.031 | 0.124 | Histamine H1 receptor antagonist | |||
| 0.148 | 0.056 | 0.148 | Nav1.6 sodium channel blocker | |||
| 0.097 | 0.008 | 0.099 | 5 Hydroxytryptamine 7 agonist | 0.099 0.007 DBMET00948 0.099 0.007 DBMET03669 | DBMET03669 | |
| 0.128 | 0.039 | 0.128 | Antihistaminic | |||
| 0.102 | 0.015 | 0.102 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.123 | 0.038 | 0.123 | Histamine antagonist | |||
| 0.167 | 0.084 | 0.214 | Lipocortins synthesis antagonist | 0.164 0.087 DBMET00948 0.214 0.048 DBMET03667 0.141 0.119 DBMET03668 0.164 0.087 DBMET03669 | DBMET03667 | |
| 0.097 | 0.017 | 0.112 | GABA A receptor antagonist | 0.048 0.043 DBMET00948 0.112 0.013 DBMET03667 0.048 0.043 DBMET03669 | DBMET03667 | |
| 0.093 | 0.019 | 0.093 | 5 Hydroxytryptamine 3 agonist | |||
| 0.124 | 0.056 | 0.124 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.087 | 0.019 | 0.124 | GABA receptor antagonist | 0.048 0.047 DBMET00948 0.124 0.012 DBMET03667 0.048 0.047 DBMET03669 | DBMET03667 | |
| 0.11 | 0.046 | 0.11 | Prolactin inhibitor | 0.1 0.055 DBMET00948 0.1 0.055 DBMET03669 | ||
| 0.233 | 0.173 | 0.345 | Antiobesity | 0.345 0.09 DBMET03667 0.252 0.154 DBMET03670 | DBMET03667 | |
| 0.133 | 0.075 | 0.133 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.163 | 0.105 | 0.163 | Psychostimulant | |||
| 0.081 | 0.024 | 0.081 | Acetylcholine M5 receptor antagonist | 0.073 0.028 DBMET00948 0.073 0.028 DBMET03669 | ||
| 0.089 | 0.033 | 0.089 | Alpha adrenoreceptor agonist | 0.062 0.053 DBMET00948 0.062 0.053 DBMET03669 | ||
| 0.094 | 0.038 | 0.094 | Somatostatin 1 agonist | 0.09 0.042 DBMET00948 0.074 0.058 DBMET03667 0.09 0.042 DBMET03669 | ||
| 0.077 | 0.021 | 0.077 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.073 0.024 DBMET00948 0.059 0.046 DBMET03667 0.073 0.024 DBMET03669 | ||
| 0.142 | 0.087 | 0.142 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.071 | 0.017 | 0.186 | Thromboxane synthase inhibitor | 0.058 0.031 DBMET00948 0.186 0.004 DBMET03667 0.051 0.046 DBMET03668 0.058 0.031 DBMET03669 | DBMET03667 | |
| 0.066 | 0.013 | 0.066 | CDK7/cyclin H inhibitor | 0.054 0.02 DBMET00948 0.053 0.021 DBMET03667 0.053 0.021 DBMET03668 0.054 0.02 DBMET03669 | ||
| 0.064 | 0.013 | 0.064 | Histamine H2 receptor agonist | |||
| 0.099 | 0.049 | 0.099 | Alpha 2 adrenoreceptor antagonist | 0.076 0.072 DBMET00948 0.076 0.072 DBMET03669 | ||
| 0.067 | 0.019 | 0.067 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.11 | 0.062 | 0.138 | Nav1.4 sodium channel blocker | 0.1 0.075 DBMET00948 0.137 0.04 DBMET03667 0.1 0.075 DBMET03669 0.138 0.039 DBMET03670 | DBMET03670 | |
| 0.096 | 0.049 | 0.096 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.06 | 0.016 | 0.06 | CC chemokine 4 receptor antagonist | 0.047 0.033 DBMET03667 | ||
| 0.072 | 0.028 | 0.072 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.057 | 0.016 | 0.057 | Benzodiazepine antagonist | |||
| 0.121 | 0.083 | 0.121 | Toll-Like receptor antagonist | |||
| 0.052 | 0.014 | 0.052 | Somatostatin 4 agonist | 0.041 0.021 DBMET00948 0.041 0.021 DBMET03669 | ||
| 0.119 | 0.082 | 0.129 | Antibacterial (Helicobacter pylori) | 0.129 0.068 DBMET03667 | DBMET03667 | |
| 0.078 | 0.041 | 0.078 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.055 | 0.018 | 0.055 | Melanocortin 1 antagonist | 0.04 0.024 DBMET03667 0.038 0.027 DBMET03668 | ||
| 0.068 | 0.033 | 0.068 | Bombesin 1 receptor agonist | 0.055 0.047 DBMET00948 0.065 0.035 DBMET03667 0.061 0.04 DBMET03668 0.055 0.047 DBMET03669 | ||
| 0.057 | 0.023 | 0.057 | Melanocortin antagonist | 0.045 0.036 DBMET00948 0.048 0.032 DBMET03667 0.045 0.035 DBMET03668 0.045 0.036 DBMET03669 | ||
| 0.041 | 0.007 | 0.041 | Melatonin 3 antagonist | 0.02 0.012 DBMET00948 0.022 0.011 DBMET03667 0.026 0.01 DBMET03668 0.02 0.012 DBMET03669 | ||
| 0.041 | 0.007 | 0.041 | 5 Hydroxytryptamine 6 agonist | |||
| 0.049 | 0.015 | 0.055 | Heme oxygenase inhibitor | 0.055 0.008 DBMET03667 0.042 0.032 DBMET03668 | DBMET03667 | |
| 0.048 | 0.015 | 0.048 | Bombesin 1 receptor antagonist | 0.039 0.023 DBMET00948 0.041 0.021 DBMET03667 0.045 0.018 DBMET03668 0.039 0.023 DBMET03669 | ||
| 0.071 | 0.038 | 0.096 | 5 Hydroxytryptamine uptake inhibitor | 0.096 0.028 DBMET03668 | DBMET03668 | |
| 0.054 | 0.021 | 0.054 | Melanocortin 4 antagonist | 0.04 0.032 DBMET00948 0.045 0.026 DBMET03667 0.042 0.029 DBMET03668 0.04 0.032 DBMET03669 | ||
| 0.07 | 0.038 | 0.07 | Aryl hydrocarbon receptor antagonist | |||
| 0.069 | 0.037 | 0.069 | 5 Hydroxytryptamine 2A agonist | |||
| 0.052 | 0.02 | 0.052 | Geranyltranstransferase inhibitor | 0.046 0.028 DBMET00948 0.042 0.033 DBMET03667 0.046 0.028 DBMET03669 | ||
| 0.093 | 0.062 | 0.093 | Alpha 2d adrenoreceptor antagonist | |||
| 0.05 | 0.019 | 0.05 | Histamine H1 receptor agonist | |||
| 0.155 | 0.125 | 0.155 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.15 0.133 DBMET00948 0.15 0.133 DBMET03669 | ||
| 0.053 | 0.025 | 0.053 | Oleamide hydrolase inhibitor | 0.042 0.035 DBMET03667 | ||
| 0.037 | 0.01 | 0.037 | Urotensin II agonist | 0.029 0.016 DBMET00948 0.029 0.016 DBMET03669 | ||
| 0.077 | 0.051 | 0.077 | Alpha 2a adrenoreceptor antagonist | |||
| 0.088 | 0.062 | 0.088 | Phosphodiesterase I inhibitor | 0.084 0.07 DBMET03667 | ||
| 0.094 | 0.07 | 0.094 | Vascular endothelial growth factor 1 antagonist | |||
| 0.051 | 0.028 | 0.052 | Bombesin antagonist | 0.046 0.037 DBMET00948 0.052 0.026 DBMET03667 0.048 0.033 DBMET03668 0.046 0.037 DBMET03669 | DBMET03667 | |
| 0.023 | 0.004 | 0.023 | Melatonin 5 antagonist | 0.011 0.008 DBMET03668 | ||
| 0.066 | 0.047 | 0.066 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.056 | 0.037 | 0.058 | Bombesin 3 receptor antagonist | 0.058 0.035 DBMET03667 | DBMET03667 | |
| 0.044 | 0.027 | 0.044 | GHS receptor agonist | |||
| 0.06 | 0.042 | 0.06 | CXC chemokine 4 receptor antagonist | |||
| 0.068 | 0.052 | 0.068 | Amidase inhibitor | |||
| 0.116 | 0.102 | 0.116 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.057 | 0.043 | 0.057 | CDK9/cyclin T1 inhibitor | |||
| 0.066 | 0.052 | 0.066 | Exportin-1 inhibitor | 0.066 0.052 DBMET03667 | ||
| 0.058 | 0.045 | 0.063 | Gonadotropin-releasing hormone receptor agonist | 0.063 0.034 DBMET03668 | DBMET03668 | |
| 0.235 | 0.222 | 0.339 | Calcium channel L-type activator | 0.339 0.126 DBMET00948 0.313 0.146 DBMET03667 0.339 0.126 DBMET03669 | DBMET03669 | |
| 0.034 | 0.022 | 0.034 | Growth hormone releasing factor agonist | |||
| 0.153 | 0.141 | 0.153 | MAP kinase kinase 5 inhibitor | 0.153 0.14 DBMET00948 0.153 0.14 DBMET03669 | ||
| 0.042 | 0.032 | 0.092 | Dopamine D2 agonist | 0.052 0.026 DBMET00948 0.052 0.026 DBMET03669 0.092 0.012 DBMET03670 | DBMET03670 | |
| 0.097 | 0.087 | 0.097 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.049 | 0.039 | 0.049 | 5 Hydroxytryptamine 2 agonist | |||
| 0.193 | 0.185 | 0.193 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.025 | 0.018 | 0.025 | 5 Hydroxytryptamine 1F agonist | |||
| 0.012 | 0.005 | 0.012 | Angiotensin AT2 receptor agonist | |||
| 0.036 | 0.029 | 0.036 | Somatostatin 1 antagonist | |||
| 0.027 | 0.021 | 0.027 | Melatonin antagonist | |||
| 0.073 | 0.068 | 0.12 | Adrenaline agonist | 0.12 0.025 DBMET00948 0.12 0.025 DBMET03669 | DBMET03669 | |
| 0.077 | 0.073 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.02 | 0.017 | 0.101 | Estrone sulfatase inhibitor | 0.02 0.017 DBMET00948 0.023 0.014 DBMET03667 0.02 0.017 DBMET03669 0.101 0.004 DBMET03670 | DBMET03670 | |
| 0.043 | 0.04 | 0.043 | Benzodiazepine inverse agonist | |||
| 0.055 | 0.052 | 0.058 | Cyclin D1 inhibitor | 0.058 0.046 DBMET00948 0.058 0.046 DBMET03669 | DBMET03669 | |
| 0.023 | 0.026 | 0.026 | Thymidine phosphorylase inhibitor | 0.024 0.022 DBMET00948 0.026 0.018 DBMET03667 0.024 0.022 DBMET03669 | DBMET03667 | |
| 0.029 | 0.033 | 0.294 | Cholecystokinin A antagonist | 0.034 0.028 DBMET03667 0.294 0.004 DBMET03670 | DBMET03670 | |
| 0.043 | 0.048 | 0.048 | Dopamine beta hydroxylase inhibitor | 0.048 0.034 DBMET03667 | DBMET03667 | |
| 0.203 | 0.21 | 0.333 | 15-Lipoxygenase inhibitor | 0.333 0.109 DBMET00948 0.212 0.2 DBMET03667 0.333 0.109 DBMET03669 | DBMET03669 | |
| 0.124 | 0.132 | 0.139 | CF transmembrane conductance regulator agonist | 0.139 0.098 DBMET00948 0.139 0.098 DBMET03669 | DBMET03669 | |
| 0.028 | 0.037 | 0.258 | Cholecystokinin antagonist | 0.046 0.027 DBMET03667 0.258 0.004 DBMET03670 | DBMET03670 | |
| 0.018 | 0.027 | 0.022 | Bombesin agonist | 0.022 0.016 DBMET03667 | DBMET03667 | |
| 0.008 | 0.02 | 0.025 | Egl nine homolog 3 inhibitor | 0.025 0.004 DBMET03667 | DBMET03667 | |
| 0.014 | 0.027 | 0.018 | Bombesin 3 receptor agonist | 0.018 0.015 DBMET03667 | DBMET03667 | |
| 0.029 | 0.043 | 0.536 | Cholecystokinin B agonist | 0.536 0.002 DBMET03670 | DBMET03670 | |
| 0.117 | 0.132 | 0.133 | GABA C receptor rho-2 antagonist | 0.133 0.1 DBMET03667 | DBMET03667 | |
| 0.018 | 0.037 | 0.219 | Cholecystokinin B antagonist | 0.219 0.004 DBMET03670 | DBMET03670 | |
| 0.034 | 0.058 | 0.08 | AMPA receptor antagonist | 0.08 0.017 DBMET03667 | DBMET03667 | |
| 0.019 | 0.045 | 0.035 | Plasma kallikrein inhibitor | 0.035 0.022 DBMET03667 | DBMET03667 | |
| 0.109 | 0.136 | 0.208 | Heat shock protein 90 antagonist | 0.208 0.034 DBMET00948 0.132 0.095 DBMET03668 0.208 0.034 DBMET03669 | DBMET03669 | |
| 0.068 | 0.097 | 0.082 | Factor XII inhibitor | 0.082 0.063 DBMET03667 | DBMET03667 | |
| 0.089 | 0.121 | 0.146 | Bone formation stimulant | 0.139 0.068 DBMET00948 0.146 0.062 DBMET03667 0.139 0.068 DBMET03669 | DBMET03667 | |
| 0.045 | 0.076 | 0.075 | Sphingosine 1-phosphate receptor 1 antagonist | 0.075 0.015 DBMET03667 | DBMET03667 | |
| 0.08 | 0.116 | 0.198 | Adenylate kinase inhibitor | 0.198 0.015 DBMET03667 | DBMET03667 | |
| 0.111 | 0.147 | 0.192 | Heat shock protein 90 alpha antagonist | 0.192 0.054 DBMET00948 0.192 0.054 DBMET03669 | DBMET03669 | |
| 0.029 | 0.071 | 0.043 | Kallikrein inhibitor | 0.043 0.039 DBMET03667 | DBMET03667 | |
| 0.009 | 0.052 | 0.074 | AMPA 1 receptor antagonist | 0.074 0.008 DBMET03667 | DBMET03667 | |
| 0.026 | 0.069 | 0.063 | Adenosine deaminase inhibitor | 0.063 0.018 DBMET03667 | DBMET03667 | |
| 0.013 | 0.057 | 0.021 | Dopamine D1 agonist | 0.021 0.02 DBMET03670 | DBMET03670 | |
| 0.015 | 0.06 | 0.036 | Protocollagen prolyl hydroxylase inhibitor | 0.036 0.009 DBMET03667 | DBMET03667 | |
| 0.104 | 0.152 | 0.183 | Growth hormone agonist | 0.183 0.066 DBMET03667 | DBMET03667 | |
| 0.064 | 0.115 | 0.096 | Breast cancer-resistant protein inhibitor | 0.096 0.059 DBMET03670 | DBMET03670 | |
| 0.107 | 0.16 | 0.122 | Adenylate cyclase stimulant | 0.122 0.12 DBMET00948 0.122 0.12 DBMET03669 | DBMET03669 | |
| 0.007 | 0.064 | 0.365 | Cholecystokinin agonist | 0.365 0.002 DBMET03670 | DBMET03670 | |
| 0.034 | 0.093 | 0.053 | Bombesin 2 receptor antagonist | 0.053 0.029 DBMET03667 | DBMET03667 | |
| 0.029 | 0.088 | 0.047 | GABA B receptor antagonist | 0.047 0.023 DBMET03667 | DBMET03667 | |
| 0.058 | 0.121 | 0.092 | Sphingosine 1-phosphate receptor antagonist | 0.092 0.027 DBMET03667 | DBMET03667 | |
| 0.058 | 0.121 | 0.116 | GABA B receptor agonist | 0.116 0.009 DBMET03667 | DBMET03667 | |
| 0.025 | 0.088 | 0.057 | AMPA 4 receptor antagonist | 0.057 0.011 DBMET03667 | DBMET03667 | |
| 0.007 | 0.074 | 0.272 | Cholecystokinin A agonist | 0.272 0.002 DBMET03670 | DBMET03670 | |
| 0.071 | 0.14 | 0.105 | GABA C receptor antagonist | 0.105 0.071 DBMET03667 | DBMET03667 | |
| 0.049 | 0.122 | 0.06 | Beta 2 adrenoreceptor agonist | 0.06 0.05 DBMET00948 0.06 0.05 DBMET03669 | DBMET03669 | |
| 0.033 | 0.109 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.041 DBMET00948 0.043 0.041 DBMET03669 | DBMET03669 | |
| 0.033 | 0.112 | 0.054 | Carbonic anhydrase stimulant | 0.054 0.048 DBMET03667 | DBMET03667 | |
| 0.016 | 0.097 | 0.067 | NMDA receptor subunit 3A antagonist | 0.067 0.015 DBMET03667 | DBMET03667 | |
| 0.053 | 0.135 | 0.08 | Antineoplastic alkaloid | 0.08 0.065 DBMET00948 0.08 0.065 DBMET03669 | DBMET03669 | |
| 0.013 | 0.097 | 0.112 | Kinesin-like protein 1 inhibitor | 0.112 0.006 DBMET03668 | DBMET03668 | |
| 0.013 | 0.097 | 0.112 | Kinesin antagonist | 0.112 0.006 DBMET03668 | DBMET03668 | |
| 0.058 | 0.143 | 0.116 | Protein kinase (CK2) alpha inhibitor | 0.116 0.065 DBMET03667 | DBMET03667 | |
| 0.06 | 0.161 | 0.114 | GABA C receptor rho-1 antagonist | 0.114 0.045 DBMET03667 | DBMET03667 | |
| 0.084 | 0.184 | 0.208 | Amyloid beta aggregation inhibitor | 0.208 0.074 DBMET00948 0.208 0.074 DBMET03669 | DBMET03669 | |
| 0.02 | 0.127 | 0.055 | Sphingosine 1-phosphate receptor agonist | 0.055 0.02 DBMET03667 | DBMET03667 | |
| 0.091 | 0.211 | 0.208 | HERG channel blocker | 0.208 0.086 DBMET03668 | DBMET03668 | |
| 0.112 | 0.234 | 0.164 | Catenin beta inhibitor | 0.164 0.076 DBMET03667 | DBMET03667 | |
| 0.029 | 0.155 | 0.066 | Check point kinase 1 inhibitor | 0.066 0.05 DBMET03668 | DBMET03668 | |
| 0.058 | 0.185 | 0.122 | AMP-activated protein kinase stimulant | 0.122 0.047 DBMET03667 | DBMET03667 | |
| 0.04 | 0.167 | 0.072 | HIV-1 integrase inhibitor | 0.072 0.045 DBMET03667 0.065 0.056 DBMET03670 | DBMET03667 | |
| 0.003 | 0.144 | 0.015 | Egl nine homolog 1 inhibitor | 0.015 0.01 DBMET03667 | DBMET03667 | |
| 0.039 | 0.183 | 0.081 | Glycine receptor antagonist | 0.081 0.055 DBMET03670 | DBMET03670 | |
| 0.047 | 0.195 | 0.073 | MDM2 inhibitor | 0.073 0.032 DBMET03667 | DBMET03667 | |
| 0.126 | 0.277 | 0.39 | Angiogenesis inhibitor | 0.39 0.056 DBMET03670 | DBMET03670 | |
| 0.046 | 0.2 | 0.207 | GABA C receptor agonist | 0.207 0.019 DBMET03667 | DBMET03667 | |
| 0.025 | 0.185 | 0.057 | Adrenaline uptake inhibitor | 0.057 0.048 DBMET03668 | DBMET03668 | |
| 0.08 | 0.244 | 0.184 | Potassium channel (Voltage-sensitive) blocker | 0.184 0.108 DBMET03668 | DBMET03668 | |
| 0.013 | 0.182 | 0.033 | Glutamate (mGluR3) antagonist | 0.033 0.031 DBMET03667 | DBMET03667 | |
| 0.021 | 0.225 | 0.04 | Glutamate (mGluR4) antagonist | 0.04 0.038 DBMET03667 | DBMET03667 | |
| 0.08 | 0.321 | 0.155 | Sphingosine 1-phosphate receptor 5 antagonist | 0.155 0.054 DBMET03667 | DBMET03667 | |
| 0.011 | 0.256 | 0.24 | Prostaglandin antagonist | 0.24 0.005 DBMET03667 | DBMET03667 | |
| 0.004 | 0.255 | 0.125 | Prostaglandin D2 antagonist | 0.125 0.004 DBMET03667 | DBMET03667 | |
| 0.008 | 0.273 | 0.025 | Thyroid hormone agonist | 0.025 0.02 DBMET03667 | DBMET03667 | |
| 0.057 | 0.325 | 0.106 | Sphingosine 1-phosphate receptor 4 antagonist | 0.106 0.104 DBMET03667 | DBMET03667 | |
| 0.011 | 0.279 | 0.05 | Thromboxane antagonist | 0.05 0.041 DBMET03667 | DBMET03667 | |
| 0.059 | 0.33 | 0.239 | Platelet antagonist | 0.239 0.077 DBMET03667 | DBMET03667 | |
| 0.049 | 0.323 | 0.107 | Interleukin 8 antagonist | 0.107 0.082 DBMET03667 | DBMET03667 | |
| 0.085 | 0.377 | 0.234 | Gastrin inhibitor | 0.234 0.1 DBMET03667 | DBMET03667 | |
| 0.098 | 0.396 | 0.34 | Sodium/bile acid cotransporter inhibitor | 0.34 0.046 DBMET03667 | DBMET03667 | |
| 0.03 | 0.342 | 0.082 | HIV-1 integrase (Overall Integration) inhibitor | 0.082 0.075 DBMET03667 | DBMET03667 | |
| 0.095 | 0.417 | 0.227 | Histamine release inhibitor | 0.227 0.174 DBMET03667 | DBMET03667 | |
| 0.01 | 0.347 | 0.132 | NMDA 2B receptor antagonist | 0.132 0.01 DBMET03670 | DBMET03670 | |
| 0.007 | 0.348 | 0.03 | NMDA 2D receptor antagonist | 0.03 0.016 DBMET03670 | DBMET03670 | |
| 0.037 | 0.385 | 0.124 | DOPA decarboxylase inhibitor | 0.124 0.04 DBMET03667 | DBMET03667 | |
| 0.028 | 0.379 | 0.138 | Multidrug resistance-associated protein 1 inhibitor | 0.138 0.032 DBMET03670 | DBMET03670 | |
| 0.036 | 0.395 | 0.188 | Dual specificity phosphatase inhibitor | 0.188 0.062 DBMET03670 | DBMET03670 | |
| 0.024 | 0.387 | 0.075 | Potassium channel large-conductance Ca-activated activator | 0.075 0.039 DBMET00948 0.075 0.039 DBMET03669 | DBMET03669 | |
| 0.03 | 0.394 | 0.089 | Bile acid receptor antagonist | 0.089 0.076 DBMET03667 | DBMET03667 | |
| 0.009 | 0.382 | 0.075 | Selectin antagonist | 0.075 0.039 DBMET03670 | DBMET03670 | |
| 0.012 | 0.425 | 0.073 | CDC25A inhibitor | 0.073 0.051 DBMET03670 | DBMET03670 | |
| 0.011 | 0.427 | 0.063 | Histidine decarboxylase inhibitor | 0.063 0.058 DBMET03667 | DBMET03667 | |
| 0.013 | 0.49 | 0.053 | Carnitine palmitoyltransferase 1B inhibitor | 0.053 0.025 DBMET03667 | DBMET03667 | |
| 0.032 | 0.516 | 0.143 | Hemostatic | 0.143 0.077 DBMET03670 | DBMET03670 | |
| 0.022 | 0.53 | 0.261 | Angiogenesis stimulant | 0.261 0.065 DBMET03670 | DBMET03670 | |
| 0.045 | 0.59 | 0.201 | Toll-Like receptor 7 agonist | 0.201 0.2 DBMET03667 | DBMET03667 | |
| 0.016 | 0.59 | 0.243 | Anticoagulant | 0.243 0.04 DBMET03670 | DBMET03670 | |
| 0.004 | 0.588 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 DBMET03670 | DBMET03670 | |
| 0.014 | 0.626 | 0.143 | Dual specificity phosphatase 3 inhibitor | 0.143 0.103 DBMET03670 | DBMET03670 | |
| 0.038 | 0.686 | 0.339 | Cyclophilin D inhibitor | 0.339 0.131 DBMET03667 | DBMET03667 | |
| 0.019 | 0.726 | 0.164 | Platelet adhesion inhibitor | 0.164 0.092 DBMET03670 | DBMET03670 | |
| 0.041 | 0.893 | 0.237 | Interleukin 2 agonist | 0.237 0.134 DBMET03667 | DBMET03667 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |